We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$9.33M
Cap. Flow %
-0.27%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135

Top Buys

Rank Stock Value
1
JNPR
Juniper Networks
JNPR
+$162M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS
Ansys
ANSS
+$119M
4
X
US Steel
X
+$104M
5
CTLT
CATALENT, INC.
CTLT
+$93.3M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$561M
2
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$120M
3
IMGN
Immunogen Inc
IMGN
+$56.8M
4
CPRI icon
Capri Holdings
CPRI
+$44.2M
5
PXD
Pioneer Natural Resource Co.
PXD
+$34M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Materials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
276
Sarepta Therapeutics
SRPT
$1.77B
$882K 0.03%
6,813
-16,295
-71% -$2M
CYH icon
277
Community Health Systems
CYH
$416M
$875K 0.03%
+250,000
New +$845K
NKTR icon
278
Nektar Therapeutics
NKTR
$2.48B
$874K 0.03%
62,375
-21,008
-25% -$220K
NKTX icon
279
Nkarta
NKTX
$164M
$865K 0.02%
+80,000
New +$832K
BMBL icon
280
Bumble
BMBL
$372M
$851K 0.02%
75,000
-550,000
-88% -$7.01M
RLAY icon
281
Relay Therapeutics
RLAY
$4.3B
$830K 0.02%
100,039
-33,694
-25% -$329K
ARDX icon
282
Ardelyx
ARDX
$1.2B
$817K 0.02%
111,889
-92,711
-45% -$793K
LTC
283
LTC Properties
LTC
$2.13B
$810K 0.02%
24,925
-30,372
-55% -$968K
ALLK
284
DELISTED
Allakos
ALLK
$808K 0.02%
+641,665
New +$997K
CRC icon
285
California Resources
CRC
$4.67B
$801K 0.02%
14,536
-583
-4% -$30.4K
OVID icon
286
Ovid Therapeutics
OVID
$495M
$791K 0.02%
259,500
+115,000
+80% +$385K
SONO icon
287
Sonos
SONO
$1.83B
$762K 0.02%
+40,000
New +$709K
REPL icon
288
Replimune Group
REPL
$1.08B
$760K 0.02%
92,991
-7,009
-7% -$57.5K
HLVX
289
DELISTED
HilleVax
HLVX
$760K 0.02%
45,676
-15,383
-25% -$246K
MLYS icon
290
Mineralys Therapeutics
MLYS
$2.38B
$755K 0.02%
58,474
-127,694
-69% -$1.58M
VTYX
291
DELISTED
Ventyx Biosciences
VTYX
$737K 0.02%
+134,000
New +$613K
SRRK icon
292
Scholar Rock
SRRK
$6.41B
$735K 0.02%
41,378
-43,751
-51% -$689K
BCAB icon
293
BioAtla
BCAB
$5.53M
$722K 0.02%
4,195
+587
+16% +$72.9K
BKD icon
294
Brookdale Senior Living
BKD
$3.43B
$720K 0.02%
109,000
+70,834
+186% +$413K
AXSM icon
295
Axsome Therapeutics
AXSM
$10.8B
$712K 0.02%
8,918
-3,004
-25% -$252K
SPKL
296
Spark I Acquisition Corp
SPKL
$101M
$708K 0.02%
+68,991
New +$705K
INFA
297
DELISTED
Informatica
INFA
$700K 0.02%
20,000
-75,000
-79% -$2.36M
SDGR icon
298
Schrodinger
SDGR
$1.33B
$699K 0.02%
25,906
-4,726
-15% -$132K
AFRM icon
299
Affirm
AFRM
$25.6B
$689K 0.02%
+18,500
New +$738K
PD icon
300
PagerDuty
PD
$856M
$680K 0.02%
+30,000
New +$712K
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.